Literature DB >> 2972365

Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.

F Vánky1, G Stuber, J Willems, K Sjöwall, B Larsson, K Böök, T Ivert, A Péterffy, E Klein.   

Abstract

In 54 patients with lung and 14 with ovarian carcinomas the quantitative variations of the major histocompatibility complex (MHC)-determined class I and class II antigens of the tumor cells were related to their in vitro interaction with blood lymphocytes, to the lymphoid infiltration of the tumors, and to the metastatic state of the disease. The tumor cell-lymphocyte interaction was measured by the proliferative response in mixed lymphocyte tumor cell culture and by the cytotoxic activity of the lymphocytes. The results showed that (1) none of the 23 tumors from patients with disseminated disease were lysed; (2) class I-negative tumors were not damaged; (3) lymphoid infiltration was present in a higher proportion of class II-positive tumors; and (4) both MHC-positive and -negative tumors were found among the disseminated tumors. The requirement of class I expression in the lytic interaction substantiates our earlier conclusion concerning the cytotoxic T lymphocyte nature of lymphocyte-mediated auto-tumor lysis. The lack of auto-tumor lysis in patients with metastases suggests impairment of lymphocyte function in advanced stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972365     DOI: 10.1007/bf00205442

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  52 in total

1.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

2.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

3.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

4.  Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.

Authors:  B M Vose; F Vanky; E Klein
Journal:  Int J Cancer       Date:  1977-10-15       Impact factor: 7.396

5.  Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.

Authors:  T E Roberts; U Shipton; M Moore
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

6.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

7.  Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.

Authors:  H C Umpleby; D Heinemann; M O Symes; R C Williamson
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

8.  The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.

Authors:  D Taramelli; G Fossati; A Balsari; R Marolda; G Parmiani
Journal:  Int J Cancer       Date:  1984-12-15       Impact factor: 7.396

9.  Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.

Authors:  F Vánky; E Klein; J Willems; K Böök; T Ivert; A Péterffy; U Nilsonne; A Kreicbergs; T Aparisi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?

Authors:  T O Rognum; P Brandtzaeg; E Thorud
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  12 in total

1.  Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine.

Authors:  B S Sharma; L Balazs; A Jin; J C Wang; W B Jolley; R K Robins
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.

Authors:  F Vánky; G Stuber; S Rotstein; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.

Authors:  P Koldovsky; I Haas; H Bier; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation.

Authors:  G Stuber; F Vánky; E Pócsik; M Benczúr; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.

Authors:  P Wang; F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Influence of LAK cells on expression of HLA-DR antigen on laryngeal carcinoma cell line in new culture systems.

Authors:  H Kumazawa; T Kumazawa; T Tachikawa; S Sai; T Yamashita; K Kawamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

9.  Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.

Authors:  G Pawelec; H Schmidt; A Rehbein; F Busch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.

Authors:  F Vánky; P Wang; M Patarroyo; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.